Profile data is unavailable for this security.
About the company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
- Revenue in HKD (TTM)804.82m
- Net income in HKD-70.88m
- Incorporated1996
- Employees925.00
- LocationShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdZhangjiang Hi-tech ParkNo.308 Cailun RoadPudong District, Zhangjiang Hi-tech ParkSHANGHAI 201210ChinaCHN
- Phone+86 2 158553583
- Fax+86 2 158553893
- Websitehttp://www.fd-zj.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.66m | 4.56bn | 197.00 | -- | 5.50 | -- | -- | -0.7656 | -0.7656 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 855.89m | 36.23m | 4.83bn | 714.00 | 122.11 | 1.94 | 36.65 | 5.64 | 0.0636 | 0.0636 | 1.51 | 4.00 | 0.2530 | 1.34 | 1.73 | 1,052,750.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 194.85m | 5.03bn | 2.09k | 33.34 | 1.13 | 10.01 | 2.42 | 0.0708 | 0.0708 | 0.6806 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,006,892.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.86bn | 488.24m | 5.62bn | 3.89k | 11.52 | 0.6814 | 4.55 | 0.7155 | 0.3812 | 0.3812 | 6.14 | 6.44 | 0.482 | 0.8615 | 6.00 | 1,968,907.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
| Ocumension Therapeutics | 614.92m | -281.89m | 5.63bn | 505.00 | -- | 1.36 | -- | 9.15 | -0.3763 | -0.3763 | 0.8212 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,257,500.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.71bn | 515.36m | 7.38bn | 789.00 | 14.33 | 1.83 | 11.76 | 4.32 | 0.6157 | 0.6157 | 2.04 | 4.81 | 0.3878 | 0.4134 | 4.92 | 2,185,246.00 | 12.14 | 15.34 | 13.34 | 17.17 | 63.00 | 68.94 | 31.29 | 39.16 | 11.43 | -- | 0.0327 | 52.52 | 5.69 | 2.38 | -7.42 | -2.09 | 20.50 | 8.76 |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 804.82m | -70.88m | 8.08bn | 925.00 | -- | -- | -- | 10.04 | -0.0448 | -0.0448 | -- | -- | -- | -- | -- | 870,076.40 | -- | 5.01 | -- | 6.20 | 88.90 | 91.92 | -8.83 | 14.50 | -- | -11.45 | -- | 48.29 | -16.61 | -7.17 | -63.42 | -29.45 | 1.11 | -- |
| China Shineway Pharmaceutical Group Ltd | 3.78bn | 936.69m | 8.08bn | 2.87k | 7.88 | 0.9148 | 10.38 | 2.14 | 1.24 | 1.24 | 5.01 | 10.68 | 0.3299 | 1.15 | 3.81 | 1,174,520.00 | 8.17 | 8.29 | 10.75 | 10.38 | 73.36 | 74.83 | 24.77 | 18.67 | 3.39 | -- | 0.0419 | 37.49 | -16.35 | 6.90 | -13.35 | 10.80 | 8.92 | 19.39 |
| CStone Pharmaceuticals | 229.01m | -426.47m | 8.18bn | 93.00 | -- | 21.22 | -- | 35.71 | -0.3272 | -0.3272 | 0.1768 | 0.2611 | 0.1487 | 1.38 | 1.68 | 1,696,351.00 | -27.69 | -39.13 | -54.45 | -60.19 | -12.18 | 66.69 | -186.23 | -170.86 | 1.20 | -29.83 | 0.554 | -- | -12.21 | -- | 75.16 | -- | -- | -- |
| SSY Group Ltd | 4.58bn | 658.92m | 8.73bn | 5.70k | 13.50 | 1.22 | 7.76 | 1.90 | 0.223 | 0.223 | 1.55 | 2.46 | 0.3616 | 2.27 | 2.11 | 751,065.60 | 5.27 | 9.41 | 6.34 | 12.43 | 42.68 | 56.47 | 14.58 | 17.65 | 2.40 | 14.91 | 0.346 | 42.91 | -10.67 | 4.49 | -19.53 | -1.36 | -8.36 | 9.73 |
| Hbm Holdings Ltd | 904.62m | 571.25m | 10.25bn | 210.00 | 15.92 | 4.23 | 17.14 | 11.33 | 0.7407 | 0.7407 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,798,829.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.63bn | -299.51m | 10.27bn | 15.58k | -- | 0.4388 | 11.31 | 0.5827 | -0.0595 | -0.0595 | 3.50 | 4.65 | 0.4326 | 1.59 | 1.71 | 1,052,279.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Luye Pharma Group Ltd | 6.98bn | 448.92m | 10.67bn | 5.12k | 22.37 | 0.6044 | 6.67 | 1.53 | 0.1193 | 0.1193 | 1.85 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,354,499.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.70bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's reporting currency: Hong Kong Dollar HKD
0.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.90m | 0.58% |
| Invesco Hong Kong Ltd.as of 31 Dec 2025 | 379.00k | 0.12% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 164.00k | 0.05% |
| Nuode Asset Management Co., Ltd.as of 30 Jun 2025 | 150.00k | 0.05% |
| DFA Australia Ltd.as of 30 Nov 2025 | 4.37k | 0.00% |
More ▼
Data from 30 Jun 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
